Phenotypic drug discovery has been highlighted in the past decade as an important strategy in the discovery of novel medical entities. How many marketed drugs are derived from phenotypic screens? From the most recent examples, what were the factors enabling target identification and validation? From the contribution of phenotypic screens to marketed drugs and the fundamental capabilities required for phenotypic discovery and platform development to recent case reports, this book brings together a wealth of experience from practitioners across academia and industry sharing their perspectives on key success factors, technologies and future directions. This book aims to equip researchers with a thought-provoking guide to the application and development of contemporary phenotypic drug discovery for clinical success.

 

Product Details